My SciELO
Custom servicesServices on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Cited by Google 
Similars in
SciELO 
Similars in Google
Share
Permalink
Journal of Negative and No Positive Results
On-line version ISSN 2529-850X
Abstract
CADENA-CORONADO, Elvira del Carmen et al. Impact of anxiety level in pediatric patients, who have neurodevelopmental disorders. JONNPR [online]. 2021, vol.6, n.5, pp.790-799. Epub Dec 04, 2023. ISSN 2529-850X. https://dx.doi.org/10.19230/jonnpr.4264.
Child development must be monitored regularly, for the early detection of alarm signals that indicate alterations in their normal evolution. This research is derived from the participation of pediatric patients with neurodevelopmental disorders.
Objective.
to evaluate anxiety in pediatric patients suffering from neurodevelopmental disorders.
Material and Methods.
The methodological design is non-experimental, descriptive and transversal. The sample consisted of 150 pediatric patients from a rehabilitation center in the state of Hidalgo, México, with a diagnosis of neurodevelopmental disorder with an age range of 4-17 years. A Spence Anxiety Scale (38 items) was applied, which was divided into 6 subscales. The application comprised a period of 30 days.
Results.
Of the 150 participants, correspondence with the female gender 49 and the male 101 children. From this, it was identified that 48% of the participants presented generalized anxiety.
Conclusion.
The results of the Spence test identify that participating women have a high level with 55 points, for men a high level with 45 points and on average it is identified that they have a high level of anxiety in general with 48 points.
Keywords : Anxiety; neurodevelopmental disorders; pediatrics.
